CT Enterprise (03839) announces profit growth, with estimated annual shareholders' net profit expected to increase to approximately 11 million US dollars year-on-year.
China Resources Enterprise International (03839) issued an announcement. According to preliminary information, the group expects to report by December 31, 2024...
CT ENTERPRISE (03839) announced that, according to preliminary information, the group expects to achieve a shareholders' comprehensive profit of approximately 11 million US dollars for the year ending December 31, 2024, compared to 2.6 million US dollars for the year ending December 31, 2023. The increase in profit is mainly due to the improved performance of the group's biochemical business, however, the group's industrial business is expected to decline due to intense competition.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
